about
Reproductive toxicity after levetiracetam administration in male rats: Evidence for role of hormonal status and oxidative stress.Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug DevelopmentPossible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsyComparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.Seizures and reproductive function: insights from female rats with epilepsyDivergent relationship of circulating CTRP3 levels between obesity and gender: a cross-sectional study.Adverse effects of antiepileptic drugs: a brief overview of important issues.The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?Zonisamide: its pharmacology, efficacy and safety in clinical trials.The adverse event profile of perampanel: meta-analysis of randomized controlled trials.The long-term safety of antiepileptic drugs.AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.Zonisamide: a review of its use in the management of adults with partial seizures.Weight change, genetics and antiepileptic drugs.Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.A Cross-sectional Study of Depressive Symptoms and Diabetes Self-care in African Americans and Hispanics/Latinos With Diabetes: The Role of Self-efficacy.Structural social support and cardiovascular disease risk factors in Hispanic/Latino adults with diabetes: results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).Long-term open-label study of adjunctive topiramate in infants with refractory partial-onset seizures.Variation in antiepileptic drug adherence among older patients with new-onset epilepsy.Weight change associated with antiepileptic drugs.Meralgia paresthetica in the pediatric population: a propos of 2 cases.Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial.Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.Effects of adjunctive zonisamide treatment on weight and body mass index in children with partial epilepsy.Obesity and neurological disorders: Dietary perspective of a global menace.Young people with epilepsy have an increased risk of eating disorder and poor quality diet.Disease Specific Aspects of Malnutrition in Neurogeriatric Patients.Disrupted female estrous cyclicity in the intrahippocampal kainic acid mouse model of temporal lobe epilepsy.
P2860
Q33574562-11E17671-7AE7-4484-A9DC-30203AC8099AQ33677979-57F8ECEB-A692-4AB4-81A2-4C027707D241Q35427844-BA6D7FB5-DF03-40BB-B27C-8D4B8EFA7DC3Q36966140-7260D312-35DF-4DE1-A7D3-FA61C7D79661Q37180564-10B0DC48-9A53-423E-BDB4-7BFC4889BE53Q37359912-B557A723-7E29-45BC-90BB-47E201BAF52DQ37762256-23AFE9DB-C2B0-46A6-A637-C785A4D04C9BQ38018125-E12A573A-A89F-4953-9633-1F28D5755F13Q38056165-23C99115-0FBD-4914-A9F6-BEE308CDDE31Q38056166-556B516D-4934-4B01-B1EE-90750F97D9F2Q38100835-59E8ADDB-32CD-4F83-B8B2-69FE97385325Q38106856-68EF301D-F8FB-4E92-B656-38FFDB24088FQ38112213-AA81F775-EE54-4718-9601-78EEBF879AB2Q38123123-D9742453-D6FC-4B1D-A7A6-B1AB9A180849Q38168942-F6F73EF5-D5A0-4880-9178-1CF3933C9416Q39094490-DD295EA7-27DE-4F51-9AD9-D7A921D555EAQ39404106-5ECBF7C6-91BD-48E1-A7F8-A8CB401A3EBAQ39668911-118653DB-8D37-4E4D-A914-E141D84D376DQ40300449-06E239E2-AE8A-4EF0-B751-40768C992B39Q40321741-3EDD8352-EBB8-49BC-B14D-5ECE107B8223Q42838449-BB72E03F-F048-49CF-B82B-2109262DCB4CQ45783139-A08846DE-D9CF-442D-8115-5934B20D60ECQ46003207-CF29F7BB-AB7F-43C0-B775-4419D1D595A2Q46208501-47E2E9A5-AEA2-4F00-A3B9-CB2F401A85DCQ46488708-8625E16D-9DD5-4AD9-8A38-95B117DCD961Q47139736-73312868-8838-4DC5-AFE5-CF405A037EA1Q47142337-954F284B-21C1-4DEC-B3EA-C4C0D8E966EDQ47359019-72BA034B-523E-464B-A387-36E1E3C5D444Q47407155-AA96A103-D978-42EB-A818-F23F5D90FAADQ48564253-CF0C38C8-B8E8-4C93-B9A0-0752D64505D3Q53834394-DA659605-9CDC-47EE-8F98-68DA750C5532Q55128164-4EF50B8C-4D2E-4102-8A1B-C75211DC8D2AQ55342380-30BCD502-C220-4EB7-9E84-CA53CE4453EC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Weight issues for people with epilepsy--a review.
@en
Weight issues for people with epilepsy--a review.
@nl
type
label
Weight issues for people with epilepsy--a review.
@en
Weight issues for people with epilepsy--a review.
@nl
prefLabel
Weight issues for people with epilepsy--a review.
@en
Weight issues for people with epilepsy--a review.
@nl
P2860
P1433
P1476
Weight issues for people with epilepsy--a review.
@en
P2093
Elinor Ben-Menachem
P2860
P356
10.1111/J.1528-1167.2007.01402.X
P478
48 Suppl 9
P577
2007-01-01T00:00:00Z